Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early phase II study of TAC-401 in H. pylori-positive subjects
jRCT2080221982Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of TAC-401 in Helicobacter pylori infection (3 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
TAC-401
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on jRCT2080221982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221982.